Shabnam Ahmadi | Environmental Health | Editorial Board Member

Dr. Shabnam Ahmadi | Environmental Health | Editorial Board Member

Dr. Shabnam Ahmadi | Tarbiat Modares University | Iran

Dr. Shabnam Ahmadi is an accomplished environmental researcher whose work centers on advanced water and wastewater treatment technologies, with a strong emphasis on adsorption, advanced oxidation processes, nanomaterial synthesis, and pollutant degradation. Her extensive research output spans high-impact studies on removing pharmaceuticals, dyes, heavy metals, fluoride, chloramphenicol, aniline, nitrate, arsenic, biogenic amines, and other emerging contaminants from industrial and municipal effluents. She has contributed significantly to the development and optimization of novel adsorbents, including LaFeO₃ nanoparticles, graphene quantum dots, zero-valent iron composites, nickel oxide, MgO-based nanomaterials, P-γ-Fe₂O₃ nanostructures, rare-earth oxides, and green-synthesized materials, frequently applying kinetic, equilibrium, thermodynamic, and modeling approaches such as RSM, ANN, and GA. Her collaborative reviews and research articles explore sustainable, cost-effective remediation pathways using sonochemical, sonoelectrochemical, peroxydisulfate-enhanced, hydrothermal, and combined oxidation–adsorption systems for tackling recalcitrant pollutants. Dr. Ahmadi’s work extends to environmental health, where she has assessed air quality impacts such as PM10 exposure, and to food safety through studies on microbial contamination and biogenic amine formation. She has co-authored influential reviews on treatment strategies for acid mine drainage, dye-laden wastewater, ciprofloxacin removal, and novel green adsorbents, contributing to scientific advancements in environmental protection. Her multidisciplinary collaborations across environmental chemistry, materials science, microbiology, and process engineering highlight her role in shaping innovative, scalable, and sustainable solutions for water purification and pollution control, positioning her research as an important contribution to global efforts aimed at cleaner water resources and safer ecosystems.

Profile: Scopus | ORCID

Featured Publications

Falyouna, O., Maamoun, I., Ghosh, S., Malloum, A., Othmani, A., Eljamal, O., Amen, T., Oroke, A., Bornman, C., Ahmadi, S., Dehghani, M. H., Mahvi, A. H., Nasseri, S., Tyagi, I., & Koduru, J. R. (2022). Sustainable technologies for the removal of chloramphenicol from pharmaceutical industries effluent: A critical review. Journal of Molecular Liquids.

Akpomie, O., Ejechi, B. O., Banach, A. M., Adewuyi, I., Ayobola, E. D., Akpomie, K. G., Ghosh, S., & Ahmadi, S. (2022). Biogenic amine production from processed protein-based foods contaminated with Escherichia coli and Enterococcus faecalis. Journal of Food Science and Technology.

Ghosh, S., Al Sharify, Z. T., Maleka, M. F., Onyeaka, H., Maleke, M., Malloum, A., Godoy, L., Meskini, M., Rami, M. R., Ahmadi, S., Al Najjar, S. Z., Ahmed, S. M., & Dehghani, M. H. (2022). Propolis efficacy on SARS-COV viruses: A review on antimicrobial activities and molecular simulations. Environmental Science and Pollution Research.

Ghosh, S., Malloum, A., Bornman, C., Othmani, A., Osagie, C., Kashitarash, Z., Khanday, W., Ahmadi, S., & Dehghani, M. (2022). Novel green adsorbents for removal of aniline from industrial effluents: A review. Journal of Molecular Liquids.

Ghosh, S., Malloum, A., Igwegbe, C., Ighalo, J. O., Ahmadi, S., Dehghani, M., Othmani, A., Gökkuş, Ö., & Mubarak, N. (2022). New-generation adsorbents for the removal of fluoride from water and wastewater: A review. Journal of Molecular Liquids.

Eman Abdeall | Health & Medicine | Best Researcher Award

Prof. Eman Abdeall | Health & Medicine | Best Researcher Award

Head of Department | Beni-Suef Univeristy | Egypt

Prof. Eman K. A. Abdelall is an accomplished researcher specializing in pharmaceutical organic chemistry with a focus on drug synthesis, molecular design, and structure-activity relationship studies. Her extensive research portfolio demonstrates a strong commitment to the discovery and development of bioactive compounds targeting critical human diseases. She has made significant advancements in the design and synthesis of novel molecules with anti-inflammatory, anticancer, and antiviral properties, employing a multidisciplinary approach that integrates organic synthesis, computational modeling, and biological evaluation. Her recent studies include the development of quinazolinone-based compounds as dual STAT-3 and c-Src inhibitors, the design of antipyrine-celecoxib hybrid analogues with dual COX-2 and SARS-CoV-2 Mpro inhibitory activities, and the synthesis of new pyrazoles with selective anti-inflammatory potential. Prof. Abdelall’s work, published in high-impact journals such as Bioorganic Chemistry, Bioorganic and Medicinal Chemistry Letters, and Drug Development Research, reflects her expertise in rational drug design and her ability to translate molecular innovations into pharmacologically relevant candidates. With 46 peer-reviewed publications, over 1,045 citations, and an h-index of 20, her research demonstrates both quality and global impact. Her findings contribute to understanding molecular mechanisms underlying inflammation, cancer proliferation, and viral replication, offering new therapeutic strategies with enhanced efficacy and safety. Through her sustained publication record, interdisciplinary research, and consistent scientific innovation, Prof. Abdelall has established herself as a leading contributor in pharmaceutical chemistry, advancing the field of rational drug design and synthesis with high translational value for modern medicine.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

  • Abdelall, E. K. A., Lamie, P. F., Fadaly, W. A. A., & Abdelgawad, Y. Y. M. (2025). Development of novel quinazolinone-based compounds with anti-proliferative activity as dual STAT-3 and c-Src inhibitors: Design, synthesis and molecular dynamic studies. Bioorganic Chemistry, 163, 108753.

  • Abdelall, E. K. A., Elshemy, H. A. H., Labib, M. B., Philoppes, J. N., Ali, F. E. M., & Ahmed, A. K. M. (2025). Synthesis of new selective agents with dual anti-inflammatory and SARS-CoV-2 Mpro inhibitory activity: Antipyrine-celecoxib hybrid analogues; COX-2, COVID-19 cytokine storm and replication inhibitory activities. Bioorganic Chemistry, 160, (Article number not specified).

  • Abdelall, E. K. A., EL-Nahass, E. S., Abdellatif, K. R. A., Abdel-Rahman, H. M. (2021). Design, synthesis, biological assessment and in silico ADME prediction of new 2-(4-(methylsulfonyl)phenyl) benzimidazoles as selective cyclooxygenase-2 inhibitors. RSC Advances, 11, 27659.